Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intestinal transplantation

H Mäkisalo1, B G Ericzon

  • 1Department of Surgery, Helsinki University Central Hospital, Finland.

Annales Chirurgiae Et Gynaecologiae
|January 1, 1997
PubMed
Summary

Intestinal transplantation (IT) faces challenges due to immunological issues and low survival rates. Advances in immunosuppression and antiviral strategies offer hope for improved outcomes in patients with intestinal failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2019
Same author

Enhanced recovery protocol after liver resection.

The British journal of surgery·2015
Same author

Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Long-term renal function deteriorates at a similar rate among liver transplant patients with preserved renal function at 1 year and in the general population: is chronic calcineurin inhibitor nephrotoxicity overrated?

Transplantation proceedings·2013
Same author

Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Hepatocyte transplantation for inherited metabolic diseases of the liver.

Journal of internal medicine·2012

Area of Science:

  • Medicine
  • Immunology
  • Surgery

Background:

  • Intestinal transplantation (IT) has progressed slowly compared to other solid organ transplants.
  • Fewer than 200 IT procedures have been performed globally in nine years, with a 3-year survival rate of approximately 40%.

Purpose of the Study:

  • To review the challenges and potential improvements in intestinal transplantation.
  • To highlight the role of IT as a treatment for intestinal failure when total parenteral nutrition (TPN) is no longer viable.

Main Methods:

  • Review of current challenges in IT, focusing on immunological hurdles.
  • Discussion of advancements in immunosuppressive therapies and supportive care.

Main Results:

  • The primary challenge in IT is immunological rejection, requiring high-dose immunosuppression with significant side effects.
  • Infection, particularly cytomegalovirus (CMV) enteritis, is a major risk for immunocompromised recipients.

Conclusions:

  • Modern immunosuppressants like tacrolimus and mycophenolic acid, combined with antiviral prophylaxis and improved surgical techniques, are expected to enhance IT outcomes.
  • IT is increasingly recognized as a crucial treatment option for intestinal failure unresponsive to TPN.

Related Experiment Videos